Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Using the NoiSee workflow to measure signal-to-noise ratios of confocal microscopes.

Ferrand A, Schleicher KD, Ehrenfeuchter N, Heusermann W, Biehlmaier O.

Sci Rep. 2019 Feb 4;9(1):1165. doi: 10.1038/s41598-018-37781-3.

2.

NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis.

Ferrand A, Al Nabhani Z, Tapias NS, Mas E, Hugot JP, Barreau F.

Cell Mol Gastroenterol Hepatol. 2018 Oct 23;7(2):357-369. doi: 10.1016/j.jcmgh.2018.10.009. [Epub ahead of print] Review.

3.

FAK alternative splice mRNA variants expression pattern in colorectal cancer.

Devaud C, Tilkin-Mariamé AF, Vignolle-Vidoni A, Souleres P, Denadai-Souza A, Rolland C, Duthoit C, Blanpied C, Chabot S, Bouillé P, Lluel P, Vergnolle N, Racaud-Sultan C, Ferrand A.

Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32120. [Epub ahead of print]

PMID:
30628725
4.

Increasing Uptake of Silica Nanoparticles with Electroporation: From Cellular Characterization to Potential Applications.

Phonesouk E, Lechevallier S, Ferrand A, Rols MP, Bezombes C, Verelst M, Golzio M.

Materials (Basel). 2019 Jan 7;12(1). pii: E179. doi: 10.3390/ma12010179.

5.

Super-resolution microscopy demystified.

Schermelleh L, Ferrand A, Huser T, Eggeling C, Sauer M, Biehlmaier O, Drummen GPC.

Nat Cell Biol. 2019 Jan;21(1):72-84. doi: 10.1038/s41556-018-0251-8. Epub 2019 Jan 2. Review.

PMID:
30602772
6.

The complexity of physicians' understanding and management of prognostic uncertainty in neonatal hypoxic-ischemic encephalopathy.

Rasmussen LA, Cascio MA, Ferrand A, Shevell M, Racine E.

J Perinatol. 2019 Feb;39(2):278-285. doi: 10.1038/s41372-018-0296-3.

PMID:
30568164
7.

Sustainable Positive Response to Sirolimus in Juvenile Polyposis of Infancy.

Quaranta M, Laborde N, Ferrand A, Danjoux M, Vergnolle N, Barreau F, Racaud-Sultan C, Mas E.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):e38-e40. doi: 10.1097/MPG.0000000000002179. No abstract available.

PMID:
30334931
8.

Can Clinicians Be Objective? Inherent Challenges in Using Decision-Making Tools in Cases of Entrenched Disagreements.

Ferrand A, Racine E.

Am J Bioeth. 2018 Aug;18(8):80-82. doi: 10.1080/15265161.2018.1485761. No abstract available.

PMID:
30133404
9.

Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism.

Sébert M, Denadai-Souza A, Quaranta M, Racaud-Sultan C, Chabot S, Lluel P, Monjotin N, Alric L, Portier G, Kirzin S, Bonnet D, Ferrand A, Vergnolle N.

Br J Pharmacol. 2018 Sep;175(18):3656-3668. doi: 10.1111/bph.14430. Epub 2018 Aug 7.

10.

Resilience Rather than Medical Factors: How Parents Predict Quality of Life of Their Sick Newborn.

Ferrand A, Gorgos A, Ali N, Payot A.

J Pediatr. 2018 Sep;200:64-70.e5. doi: 10.1016/j.jpeds.2018.05.025. Epub 2018 Jun 27.

PMID:
29958673
11.

Imaging of native transcription factors and histone phosphorylation at high resolution in live cells.

Conic S, Desplancq D, Ferrand A, Fischer V, Heyer V, Reina San Martin B, Pontabry J, Oulad-Abdelghani M, Babu N K, Wright GD, Molina N, Weiss E, Tora L.

J Cell Biol. 2018 Apr 2;217(4):1537-1552. doi: 10.1083/jcb.201709153. Epub 2018 Feb 12.

12.

Anti-inflammatory and anticancer effects of flavonol glycosides from Diplotaxis harra through GSK3β regulation in intestinal cells.

Nasri I, Chawech R, Girardi C, Mas E, Ferrand A, Vergnolle N, Fabre N, Mezghani-Jarraya R, Racaud-Sultan C.

Pharm Biol. 2017 Dec;55(1):124-131. Epub 2016 Sep 22.

PMID:
27925497
13.

Temporal and Spatial Uncoupling of DNA Double Strand Break Repair Pathways within Mammalian Heterochromatin.

Tsouroula K, Furst A, Rogier M, Heyer V, Maglott-Roth A, Ferrand A, Reina-San-Martin B, Soutoglou E.

Mol Cell. 2016 Jul 21;63(2):293-305. doi: 10.1016/j.molcel.2016.06.002. Epub 2016 Jul 7.

14.

PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Nasri I, Bonnet D, Zwarycz B, d'Aldebert E, Khou S, Mezghani-Jarraya R, Quaranta M, Rolland C, Bonnart C, Mas E, Ferrand A, Cenac N, Magness S, Van Landeghem L, Vergnolle N, Racaud-Sultan C.

Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1;311(2):G221-36. doi: 10.1152/ajpgi.00328.2015. Epub 2016 Jun 16.

15.

Asymmetrically dividing Drosophila neuroblasts utilize two spatially and temporally independent cytokinesis pathways.

Roth M, Roubinet C, Iffländer N, Ferrand A, Cabernard C.

Nat Commun. 2015 Mar 20;6:6551. doi: 10.1038/ncomms7551.

16.

Safety and efficacy of alirocumab 150 mg every 2 weeks, a fully human proprotein convertase subtilisin/kexin type 9 monoclonal antibody: A Phase II pooled analysis.

Koren MJ, Roth EM, McKenney JM, Gipe D, Hanotin C, Ferrand AC, Wu R, Dufour R.

Postgrad Med. 2015 Mar;127(2):125-32. doi: 10.1080/00325481.2015.998987. Epub 2015 Jan 22.

PMID:
25609019
17.

Biochemical and Hematologic Manifestations of Gastric Intrinsic Factor (GIF) Deficiency: A Treatable Cause of B12 Deficiency in the Old Order Mennonite Population of Southwestern Ontario.

Ferrand A, Siu VM, Rupar CA, Napier MP, Al-Dirbashi OY, Chakraborty P, Prasad C.

JIMD Rep. 2015;18:69-77. doi: 10.1007/8904_2014_351. Epub 2014 Oct 12.

18.

Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).

Gaudet D, Kereiakes DJ, McKenney JM, Roth EM, Hanotin C, Gipe D, Du Y, Ferrand AC, Ginsberg HN, Stein EA.

Am J Cardiol. 2014 Sep 1;114(5):711-5. doi: 10.1016/j.amjcard.2014.05.060. Epub 2014 Jun 18.

19.

Acidic pH resistance of grafted chitosan on dental implant.

Campos DM, Toury B, D'Almeida M, Attik GN, Ferrand A, Renoud P, Grosgogeat B.

Odontology. 2015 May;103(2):210-7. doi: 10.1007/s10266-014-0162-5. Epub 2014 Jun 28.

PMID:
24972881
20.

Do we need to worry about mycophenolate overdose?

Filler G, Ferrand A.

Expert Opin Drug Saf. 2014 May;13(5):521-4. doi: 10.1517/14740338.2014.905540. Epub 2014 Apr 1.

PMID:
24684200
21.

Modeling of ray paths of head waves on irregular interfaces in TOFD inspection for NDE.

Ferrand A, Darmon M, Chatillon S, Deschamps M.

Ultrasonics. 2014 Sep;54(7):1851-60. doi: 10.1016/j.ultras.2013.12.007. Epub 2013 Dec 18.

PMID:
24388406
22.

Activation of Src family tyrosine kinases by ferric ions.

Baldwin GS, Lio DS, Ferrand A, Catimel B, Shehan BP, Norton RS, Cheng HC.

Biochim Biophys Acta. 2014 Mar;1844(3):487-96. doi: 10.1016/j.bbapap.2013.12.004. Epub 2013 Dec 12.

PMID:
24334106
23.

Collagen implants equipped with 'fish scale'-like nanoreservoirs of growth factors for bone regeneration.

Eap S, Ferrand A, Schiavi J, Keller L, Kokten T, Fioretti F, Mainard D, Ladam G, Benkirane-Jessel N.

Nanomedicine (Lond). 2014;9(8):1253-61. doi: 10.2217/nnm.13.122. Epub 2013 Nov 27.

PMID:
24279458
24.

Osteogenetic properties of electrospun nanofibrous PCL scaffolds equipped with chitosan-based nanoreservoirs of growth factors.

Ferrand A, Eap S, Richert L, Lemoine S, Kalaskar D, Demoustier-Champagne S, Atmani H, Mély Y, Fioretti F, Schlatter G, Kuhn L, Ladam G, Benkirane-Jessel N.

Macromol Biosci. 2014 Jan;14(1):45-55. doi: 10.1002/mabi.201300283. Epub 2013 Aug 19.

PMID:
23956214
25.

Energy efficiency, housing, equity and health.

Braubach M, Ferrand A.

Int J Public Health. 2013 Jun;58(3):331-2. doi: 10.1007/s00038-012-0441-2. No abstract available.

PMID:
23292112
26.

Identification of the F1-ATPase at the cell surface of colonic epithelial cells: role in mediating cell proliferation.

Kowalski-Chauvel A, Najib S, Tikhonova IG, Huc L, Lopez F, Martinez LO, Cohen-Jonathan-Moyal E, Ferrand A, Seva C.

J Biol Chem. 2012 Nov 30;287(49):41458-68. doi: 10.1074/jbc.M112.382465. Epub 2012 Oct 10.

27.

Electrospun nanofibrous 3D scaffold for bone tissue engineering.

Eap S, Ferrand A, Palomares CM, Hébraud A, Stoltz JF, Mainard D, Schlatter G, Benkirane-Jessel N.

Biomed Mater Eng. 2012;22(1-3):137-41. doi: 10.3233/BME-2012-0699.

PMID:
22766712
28.

Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.

McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA.

J Am Coll Cardiol. 2012 Jun 19;59(25):2344-53. doi: 10.1016/j.jacc.2012.03.007. Epub 2012 Mar 28.

29.

A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polyps.

Do C, Bertrand C, Palasse J, Delisle MB, Shulkes A, Cohen-Jonathan-Moyal E, Ferrand A, Seva C.

Cancer Prev Res (Phila). 2012 Apr;5(4):675-84. doi: 10.1158/1940-6207.CAPR-11-0408. Epub 2012 Feb 24.

30.

Smart hybrid materials equipped by nanoreservoirs of therapeutics.

Mendoza-Palomares C, Ferrand A, Facca S, Fioretti F, Ladam G, Kuchler-Bopp S, Regnier T, Mainard D, Benkirane-Jessel N.

ACS Nano. 2012 Jan 24;6(1):483-90. doi: 10.1021/nn203817t. Epub 2011 Dec 23.

PMID:
22176534
31.

αv integrin: a new gastrin target in human pancreatic cancer cells.

Cayrol C, Bertrand C, Kowalski-Chauvel A, Daulhac L, Cohen-Jonathan-Moyal E, Ferrand A, Seva C.

World J Gastroenterol. 2011 Oct 28;17(40):4488-95. doi: 10.3748/wjg.v17.i40.4488.

32.

Bone formation induced by growth factors embedded into the nanostructured particles.

Facca S, Ferrand A, Mendoza-Palomares C, Perrin-Schmitt F, Netter P, Mainard D, Liverneaux P, Benkirane-Jessel N.

J Biomed Nanotechnol. 2011 Jun;7(3):482-5.

PMID:
21830494
33.

'All-supramolecular' nanocapsules from low-molecular weight ureas through interfacial addition reaction in miniemulsion.

Groison E, Adjili S, Ferrand A, Lortie F, Portinha D, Sintes-Zydowicz N.

Macromol Rapid Commun. 2011 Mar 16;32(6):491-6. doi: 10.1002/marc.201000662. Epub 2011 Jan 21.

PMID:
21433204
34.

Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine.

Ferrand A, Lachal S, Bramante G, Kovac S, Shulkes A, Baldwin GS.

Am J Physiol Gastrointest Liver Physiol. 2010 Jul;299(1):G220-7. doi: 10.1152/ajpgi.00046.2010. Epub 2010 Apr 15.

35.

A gastrin precursor, gastrin-gly, upregulates VEGF expression in colonic epithelial cells through an HIF-1-independent mechanism.

Bertrand C, Kowalski-Chauvel A, Do C, Résa C, Najib S, Daulhac L, Wang TC, Ferrand A, Seva C.

Int J Cancer. 2010 Jun 15;126(12):2847-57. doi: 10.1002/ijc.25001.

36.

Definition of the residues required for the interaction between glycine-extended gastrin and transferrin in vitro.

Kovac S, Ferrand A, Estève JP, Mason AB, Baldwin GS.

FEBS J. 2009 Sep;276(17):4866-74. doi: 10.1111/j.1742-4658.2009.07186.x. Epub 2009 Jul 31.

37.

Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.

Ferrand A, Sandrin MS, Shulkes A, Baldwin GS.

Biochim Biophys Acta. 2009 Mar;1793(3):477-88. doi: 10.1016/j.bbamcr.2009.01.004. Epub 2009 Jan 15.

38.

Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptor.

Langer I, Tikhonova IG, Boulègue C, Estève JP, Vatinel S, Ferrand A, Moroder L, Robberecht P, Fourmy D.

Mol Pharmacol. 2009 Mar;75(3):502-13. doi: 10.1124/mol.108.051607. Epub 2008 Dec 8.

PMID:
19064631
39.

Ajuba: a new microtubule-associated protein that interacts with BUBR1 and Aurora B at kinetochores in metaphase.

Ferrand A, Chevrier V, Chauvin JP, Birnbaum D.

Biol Cell. 2009 Apr;101(4):221-35. doi: 10.1042/BC20080060.

PMID:
18710370
40.

[What is the role of nurses in hemodialysis?].

Ferrand A, Benoit L.

Soins. 2007 Oct;(719 Suppl):S12-3. French. No abstract available.

PMID:
18050868
41.

Non-cytotoxic, bifunctional EuIII and TbIII luminescent macrocyclic complexes for luminescence resonant energy-transfer experiments.

Ferrand AC, Imbert D, Chauvin AS, Vandevyver CD, Bünzli JC.

Chemistry. 2007;13(31):8678-87.

PMID:
17854102
42.

Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib.

Mulloy R, Ferrand A, Kim Y, Sordella R, Bell DW, Haber DA, Anderson KS, Settleman J.

Cancer Res. 2007 Mar 1;67(5):2325-30.

43.

AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.

Shimaoka M, Kim M, Cohen EH, Yang W, Astrof N, Peer D, Salas A, Ferrand A, Springer TA.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):13991-6. Epub 2006 Sep 8.

44.

An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway.

Vatinel S, Ferrand A, Lopez F, Kowalski-Chauvel A, Estève JP, Fourmy D, Dufresne M, Seva C.

Biochim Biophys Acta. 2006 Oct;1763(10):1098-107. Epub 2006 Jul 21.

45.

Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.

Bousquet C, Guillermet-Guibert J, Saint-Laurent N, Archer-Lahlou E, Lopez F, Fanjul M, Ferrand A, Fourmy D, Pichereaux C, Monsarrat B, Pradayrol L, Estève JP, Susini C.

EMBO J. 2006 Sep 6;25(17):3943-54. Epub 2006 Aug 17.

46.

Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.

Ferrand A, Vatinel S, Kowalski-Chauvel A, Bertrand C, Escrieut C, Fourmy D, Dufresne M, Seva C.

World J Gastroenterol. 2006 Jul 28;12(28):4498-503.

47.

Myeloproliferative disorders: premalignant, stem cell, G1 diseases?

Lelièvre H, Ferrand A, Mozziconacci MJ, Birnbaum D, Delaval B.

Leukemia. 2006 Sep;20(9):1475-80. Epub 2006 Jun 29. No abstract available.

PMID:
16810200
48.

Glycine-extended gastrin activates two independent tyrosine-kinases in upstream of p85/p110 phosphatidylinositol 3-kinase in human colonic tumour cells.

Ferrand A, Kowalski-Chauvel A, Pannequin J, Bertrand C, Fourmy D, Dufresne M, Seva C.

World J Gastroenterol. 2006 Mar 28;12(12):1859-64.

49.

Gastrin and cancer: a review.

Ferrand A, Wang TC.

Cancer Lett. 2006 Jul 8;238(1):15-29. Epub 2005 Jul 27. Review.

PMID:
16054292
50.

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.

Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, Thomas X, Guerci A, Fegueux N, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Ferrand A, Sanz M, Chomienne C, Fenaux P, Dombret H; European APL Group.

Leukemia. 2005 Jul;19(7):1153-60.

PMID:
15889156

Supplemental Content

Loading ...
Support Center